🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 17 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/06/2004 14,40 14,40 13,26 14,04 +2,63% 7,92% 52.650
04/06/2004 14,28 14,40 13,32 13,68 +2,24% 7,56% 32.117
03/06/2004 14,16 14,40 13,32 13,38 -5,11% 7,63% 40.033
02/06/2004 13,92 14,40 13,68 14,10 +2,17% 5,17% 45.833
01/06/2004 14,10 14,10 13,50 13,80 +1,77% 4,26% 50.950
28/05/2004 13,26 13,86 13,26 13,56 +0,44% 4,52% 34.433
27/05/2004 13,86 14,10 13,32 13,50 -2,17% 5,63% 59.117
26/05/2004 15,00 15,06 13,62 13,80 -2,54% 9,60% 99.567
25/05/2004 12,96 14,82 12,36 14,16 +11,85% 18,98% 226.600
24/05/2004 13,32 13,38 12,48 12,66 -0,47% 6,76% 76.550
21/05/2004 13,50 13,50 12,60 12,72 -2,75% 6,67% 58.467
20/05/2004 13,68 13,80 12,66 13,08 -2,68% 8,33% 58.017
19/05/2004 13,92 14,10 13,14 13,44 +0,90% 6,90% 137.550
18/05/2004 14,40 14,40 13,14 13,32 +0,91% 8,75% 77.667
17/05/2004 13,80 13,98 12,90 13,20 -4,76% 7,83% 78.667
14/05/2004 14,52 14,76 13,56 13,86 -3,75% 8,26% 134.667
13/05/2004 15,18 15,18 14,22 14,40 -2,83% 6,32% 44.800
12/05/2004 15,72 15,78 14,16 14,82 -5,36% 10,31% 57.950
11/05/2004 15,66 16,32 15,00 15,66 +3,57% 8,43% 79.350
10/05/2004 14,16 22,20 14,16 15,12 +5,88% 56,78% 351.750
07/05/2004 15,24 15,36 14,10 14,28 -8,11% 8,27% 93.267
06/05/2004 15,00 16,08 15,00 15,54 +1,57% 7,20% 68.217
05/05/2004 17,28 17,28 14,70 15,30 -12,67% 14,93% 124.800
04/05/2004 18,42 18,48 17,34 17,52 +0,69% 6,19% 40.633
03/05/2004 18,06 19,20 16,50 17,40 +1,05% 14,95% 112.117
30/04/2004 18,90 19,32 16,86 17,22 -8,60% 13,02% 115.817
29/04/2004 19,50 20,16 18,60 18,84 -4,56% 8,00% 35.700
28/04/2004 20,70 21,30 19,62 19,74 -7,58% 8,12% 44.167
27/04/2004 20,70 21,42 19,98 21,36 +3,49% 6,96% 50.517
26/04/2004 21,00 22,20 20,40 20,64 -0,86% 8,57% 154.083